Long Island City, NY · Founded 2014 · Privately Held (backing)
Developer of a bioinformatics platform designed to accelerate the development of novel therapeutics. Envisagenics is based in Long Island City, NY and was founded in 2014. Its last known valuation is $150 million. It has raised $40.5 million across 2 recorded rounds; the latest was a $19.2 million early-stage round in Sep 2021.
Last price · $/share
—
Implied valuation
$150.0M
Total raised
$40.5M
Last round
Early Stage VC
Sep 2021
Team — not yet on record
No current team members for Envisagenics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Envisagenics with a free account
·The complete investor list: 24 names
·Watch Envisagenics: the Monday email on marks, rounds and moves
